Data Insights SBT-101 by SwanBio Therapeutics for Adrenomyeloneuropathy (AMN): Likelihood of Approval
Data Insights (Chlorthalidone + losartan) by Laboratorios Silanes for Idiopathic (Essential) Hypertension: Likelihood of Approval
Analyst Comment Casgevy: Launch sequence and price analysis of the first marketed CRISPR therapy Alex Watt